Hematology/oncology

Healthcare systems generate a huge data collected from medical tests. Data mining is the computing process of discovering patterns in large data sets such as medical examinations. Blood diseases are not an exception; there are many test data can be collected from their patients. In this paper, we applied data mining techniques to discover the relations between blood test characteristics and blood tumor in order to predict the disease in an early stage, which can be used to enhance the curing ability. We conducted experiments in our blood test dataset using three different data mining techniques which are association rules, rule induction and deep learning. The goal of our experiments is to generate models that can distinguish patients with normal blood disease from patients who have blood tumor. We evaluated our results using different metrics applied on real data collected from Gaza European hospital in Palestine. The final results showed that association rules could give us the relationship between blood test characteristics and blood tumor. Also, it demonstrated that deep learning classifiers has the best ability to predict tumor types of blood diseases with an accuracy of 79.45%. Also, rule induction gave us an explanation of rules that describes both tumor in blood and normal hematology.

Dear Sir/Madam

We are currently hosting the Oncologist & Diagnostics Conference  which is going to be organized during August 28-30, 2017 Brussels, Belgium. With great pride and honour, we would like to invite you to participate in Oncologist & Diagnostics Conference in Brussels, Belgium

Kindly let me know about you interest toward participation as a Keynote, Speaker, Poster presentation, E-Poster and Video Presentation, delegate.
Kindly find the attached file for conference details

Kindly contact us for any sort of further assistance.
We sincerely hope that you will honour us by accepting our invitation

Regards
Celina Crystal
Manager of oncology and conferences
P 702 508 5200 Ext 8033
#[email protected]

Now and since my HGB is 8.7, ie above 7.6, the HGB when I was diagnosed with Anemia >>> MDS
why not avoid a Blood Transfusion (the 12th) and concentrate, this time, on reducing my Ferritin via Chelation and find a way to increase my Serum Copper which stands at 53, that is 23 units below the minimum normal of 85 and 117 units below the maximum normal of  170 ?

HE is defined as >1.5 x 109/L eosinophils in the blood on 2 examinations (interval >1 mo) and/or tissue HE defined by: eosinophils percentage in BM section exceeding 20% of all nucleated cells; and/or extensive eosinophilic tissue infiltration by pathologist opinion; and/or presence of marked deposition of eosinophil granule proteins (in the absence or presence of major tissue eosinophils infiltration). Eosinophilia is defined as an AEC >500/μL [1]. The severity of eosinophilia has been arbitrarily divided into mild (AEC: 500-1,500/mm3),  moderate  (AEC:  1,500-5,000/mm3),  and  severe  (AEC: >5,000/mm3) [2]. HE is defined as >1.5 x 109/L eosinophils in the blood on 2 examinations (interval >1 mo) and/or tissue HE. Subtypes of HE are hereditary (familial); primary (clonal/neoplastic)    HE,    secondary    (reactive)    HE;    hypereosinophilic    syndrome (HES) and HE of undetermined significance (HEUS) [3]. HEUS is a novel term in lieu of idiopathic hypereosinophilia [4]. Most eosinophilias are reactive [5]. Is  characterized  by  proliferation  of  non-clonal,  mature eosinophils  [2].  HE  is  cytokine-driven  in  most  cases  [3].  It  is typically caused by increased IL5 levels. Concomitant elevation in IL4 and IL13 can lead to associated hypergammaglobulinemia (Ig) E [2]. Elevated peripheral eosinophilia can be found in parasitic infection, significant atopic disease, drug hypersensitivity reactions, connective  tissue  disorders,  malignancy,  monogenic  disorders  of  immune  deficiency  or  dysregulation  with  prominent  atopy, particularly  in  the  pediatric  age  group  and  rare  hypereosinophilic  syndromes [6].

Conferenceseries LLC welcomes every one of the members from everywhere throughout the world to go to " Cancer Diagnostics Conference and Expo" amid May 08-10, 2017 at Barcelona, Spain which incorporates provoke keynote presentations, Oral talks, Poster presentations and Exhibitions. Diagnostics 2017 is the extremely uncommon gathering among the past Oncology Conferences